Ressources

Bienvenue dans notre banque interrogeable de ressources et de documentation sur l’approvisionnement plus sécuritaire et autres sujets connexes.

Fentanyl Buccal Tablet for Relief of Breakthrough Pain in Opioid-Tolerant Patients With Cancer-Related Chronic Pain

This study evaluated fentanyl buccal tablets for breakthrough pain in opioid-tolerant patients with chronic cancer pain.

Original research | 2007

About prescribers, Chronic pain

Heroin on trial: systematic review and meta-analysis of randomised trials of diamorphine-prescribing as treatment for refractory heroin addiction

To synthesise published findings for treatment with supervised injectable heroin for refractory heroin-dependence through systematic review and meta-analysis, and to examine the political and scientif

Lit review | 2015

Evidence base, Policy/Regulatory, Safer supply, About prescribers, Outcomes, Illegal drugs

Ketamine for the treatment of acute pain

Guidelines | 2021

Clinical guidance, About prescribers, Chronic pain

Mortality risk during and after opioid substitution treatment: systematic review and meta-analysis of cohort studies

To compare the risk for all cause and overdose mortality in people with opioid dependence during and after substitution treatment with methadone or buprenorphine and to characterise trends in risk of

Lit review | 2017

Mortality, Harm reduction, About prescribers, Outcomes, Illegal drugs, Substitution/OAT

New Heroin-Assisted Treatment: Recent evidence and current practices of supervised injectable heroin treatment in Europe and beyond

Book | 2012

Evidence base, Safer supply, About prescribers

Opioid Agonist Treatment (OAT) Guidance During the COVID-19 Pandemic

Provide clinical guidance to ensure the uninterrupted access to OAT medications for patients during the COVID-19 pandemic.

Guidelines | 2020

Clinical guidance, Harm reduction, About pharmacists, About prescribers

Stimulus Connect 5: My Safe Supply

Archived webinar | 2020

Safer supply, About PWUD

Supervised injectable heroin or injectable methadone versus optimised oral methadone as treatment for chronic heroin addicts in England after persistent failure in orthodox treatment (RIOTT): a randomised trial

We aimed to compare the effectiveness of supervised injectable treatment with medicinal heroin (diamorphine or diacetylmorphine) or supervised injectable methadone versus optimised oral methadone for

Original research | 2010

Evidence base, Policy/Regulatory, Safer supply, Advocacy, About prescribers, Outcomes, Illegal drugs, Substitution/OAT

The cocaine-e-cigarette – A theoretical concept of a harm reduction device for current users of smokable cocaine forms

This manuscript describes basic functionality and general specifications of a cocaine-e-cigarette as a medical device treating people with respective cocaine use disorder when cessation and substituti

Original research | 2021

Harm reduction, Safer supply, Illegal drugs, Stimulants, Stigma

The Impacts of COVID-19 on Mental Health, Substance Use, and Overdose Concerns of People Who Use Drugs in Rural Communities

Investigate the impact of COVID-19 on the mental health, substance use, and overdose concerns among people who use drugs (PWUDs) in rural communities

Original research | 2021

Illegal drugs, Rural/remote, Mental health

The perceived risk of illicit drug use and views on drug policy in the general population

This article analyzes the riskiness attached to illicit drug use by means of a social representations framework.

Original research | 2021

Policy/Regulatory, Illegal drugs

The use of diverted pharmaceutical opioids is associated with reduced risk of fentanyl exposure among people using unregulated drugs in Vancouver, Canada

The aim of this study was to assess the effects of using diverted POs on fentanyl exposure.

Original research | 2021

Evidence base, Harm reduction, Hesitancy of prescribers , Safer supply, Advocacy, About prescribers, Outcomes

Tracing a path for opium gum from Mexico as a safe supply harm reduction measure for Canada

Discusses the political and legal possibilities of safely supplying opium gum and manually extracted heroin from Mexico to Canada as a public health, harm reduction and development policy.

Commentary | 2021

Policy/Regulatory, Safer supply

Visualizing harm reduction: Methodological and ethical considerations

This paper explores the opportunities and constraints of using photo-based methods in the context of a community-based participatory research study on how to engage people living with HIV in conversat

Original research | 2015

Wrap-around services, Social services, Hospitals

“About Nothing Without Us”: A Comparative Analysis of Autonomous Organizing Among People Who Use Drugs and Psychiatrized Groups in Canada

Paralleling the development of autonomous organizations of PUD in relation to independent groups by and for various psychiatrized constituencies, this article traces the history of Canadian drug/ser

Commentary | 2016

Advocacy, About PWUD, Barriers and enablers, Illegal drugs, Peer/PWLLE program involvement

A qualitative examination of substance use service needs among people who use drugs (PWUD) with treatment and service experience in Ontario, Canada

To elicit in-depth knowledge from PWUD with lived experience of accessing services to better understand their unmet treatment and service needs, towards closing the service and treatment gap in Ontari

Original research | 2021

Policy/Regulatory, Wrap-around services, Advocacy, About PWUD, Barriers and enablers, Housing, Illegal drugs, Peer/PWLLE program involvement, Stigma

A qualitative study on overdose response in the era of COVID-19 and beyond: how to spot someone so they never have to use alone

During COVID-19 restrictions, remote spotting (e.g., using a telephone, video call, and/or a social media app) emerged to address physical distancing requirements and reduced access to harm reduction

Original research | 2021

Overdose, Harm reduction, Policy/Regulatory, Decriminalization/legalization, About PWUD, Barriers and enablers, Illegal drugs, Rural/remote, SCS/OPS

Associations between discrimination and substance use among college students in the United States from 2015–2019

This study uses 2015–2019 National College Health Assessment data to determine whether college students reporting discrimination due to sexual orientation, race/ethnicity, gender, or age report greate

Original research | 2021

Equity, Illegal drugs

Breakthrough pain in community-dwelling patients with cancer pain and noncancer pain, Part 1: Prevalence and characteristics

The aim of this study was to evaluate breakthrough pain in opioid-treated ambulatory patients with chronic cancer or noncancer pain treated in community practices.

Original research | 2010

About prescribers, Chronic pain